Juvenile Rheumatoid Arthritis

• EMA approval · 2026-07-01
  EMA Authorised: Erelzi (etanercept) — Sandoz GmbH

  Authorised status for Erelzi (etanercept) by Sandoz GmbH, expanding access to therapy for multiple inflammatory arthritis conditions.

• EMA approval · 2026-06-09
  EMA Authorised: Avtozma (tocilizumab) — Celltrion Healthcare Hungary Kft.

  Avtozma (tocilizumab) has been authorised in the EU for rheumatoid arthritis, juvenile idiopathic arthritis, cytokine release syndrome, and …